Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexanolone for PTSD and Alcohol Use Disorder in Veterans
NCT06580444Phase 2Not yet recruiting
- Sponsor
- Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
- Start
- Jan 2027
- Primary completion
- Sep 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of brexanolone in post-traumatic stress disorder (PTSD), alcohol use disorder (AUD), sponsored by Pharmacotherapies for Alcohol and Substance Use Disorders Alliance. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
brexanolone
03
Conditions
post-traumatic stress disorder (PTSD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06580444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06580444.